Literature DB >> 1343451

Heparin for oral use: preliminary studies.

O Horwitz1, W T Johnson, J J Sayen, B Roberts, A F Whereat.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 1343451      PMCID: PMC2376635     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


× No keyword cloud information.
  7 in total

Review 1.  Biologic actions of heparin.

Authors:  R D Rosenberg
Journal:  Semin Hematol       Date:  1977-10       Impact factor: 3.851

2.  Blood lipids and human atherosclerosis. II. The influence of heparin upon lipoprotein metabolism.

Authors:  D M GRAHAM; T P LYON; J W GOFMAN; H B JONES; A YANKLEY; J SIMONTON; S WHITE
Journal:  Circulation       Date:  1951-11       Impact factor: 29.690

3.  Heparin and atherosclerosis: an investigative report on the treatment of atherosclerosis.

Authors:  A G Shulman
Journal:  Biomed Pharmacother       Date:  1990       Impact factor: 6.529

4.  Unstable angina, myocardial infarction, heparin and death: medium dose heparin (not exceeding 20,000 units/day) in the treatment of patients with acute coronary event--first year and long-term comparative mortality.

Authors:  J J Sayen; R B Singer; G Peirce; O Horwitz
Journal:  Trans Am Clin Climatol Assoc       Date:  1983

5.  Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.

Authors:  A M Telford; C Wilson
Journal:  Lancet       Date:  1981-06-06       Impact factor: 79.321

Review 6.  Pharmacodynamics, clinical indications, and adverse effects of heparin.

Authors:  M D Freedman
Journal:  J Clin Pharmacol       Date:  1992-07       Impact factor: 3.126

7.  Evidence from endothelium of gastric absorption of heparin and of dextran sulfates 8000.

Authors:  L B Jaques; L M Hiebert; S M Wice
Journal:  J Lab Clin Med       Date:  1991-02
  7 in total
  1 in total

Review 1.  The quest for non-invasive delivery of bioactive macromolecules: a focus on heparins.

Authors:  Nusrat A Motlekar; Bi-Botti C Youan
Journal:  J Control Release       Date:  2006-06-14       Impact factor: 9.776

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.